Dyadic International Inc.

DYAI

Healthcare Biotechnology

Dyadic International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million, down 11.6% from fiscal 2024.

Revenue
−61.4%
EPS
n/m
Free cash flow
n/m
Total debt
+0.80%

Quarter to September 2026, against a year earlier

0.33 0.02 −5.71%
Market cap
$14.0M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
2/9
ROIC
0.00%
Net debt / EBITDA
0.5×
Payout ratio
—

Ratios over time FY16 to FY25

Returns on capital

ROIC was 0.0% in FY25, against a low of -380.1% in FY18.

ROEROIC
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
ROE−12.1%−4.0%−12.3%−21.2%−29.0%−55.8%−66.0%−80.1%−139.2%−397.8%
ROIC26.7%20.7%−380.1%−353.4%0.0%0.0%0.0%0.0%0.0%0.0%

Debt

Net debt is 0.49× a year’s EBITDA. Debt is 4.08× equity.

Debt / equityNet debt / EBITDA
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Debt / equity0.0×0.0×0.0×0.0×0.0×0.0×0.0×0.0×2.0×4.1×
Net debt / EBITDA−94.9×7.6×6.0×3.8×3.0×1.4×1.2×0.9×0.7×0.5×

Cash cycle, in days

Customers pay in 133 days and suppliers are paid in 134. Suppliers fund 1 days of working capital.

Cash cycleDays to pay suppliersDays to be paid
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Cash cycle4688720611−167−234−171−61−120−1
Days to pay suppliers197279110236260291219121147134
Days to be paid6663663162479357486027133

Per share, from FY16

Since FY16, per share: revenue has grown 21.7% a year; book value has fallen 33.9% a year.

RevenueBook value
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue1.0×1.6×2.9×3.8×3.6×5.3×6.4×6.2×7.4×5.8×
Book value1.0×1.1×1.0×0.8×0.7×0.4×0.2×0.1×0.1×0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
2 4 4 4 4 3 4 — — —
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
(12.37) (8.73) (3.89) (0.80) 20.64 52.26 51.62 36.48 31.30 —
P/S ratio
9.92 14.68 15.80 13.36 52.35 92.26 83.21 40.39 63.08 0.00
Altman Z″-Score (non-manufacturers)
(31.25) (27.03) (31.29) (12.77) (2.08) 16.78 24.41 55.15 71.82 —
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Beneish M-Score
1.00 (4.48) (2.54) (3.27) (3.36) (3.54) (2.80) (2.39) — —
P/Operating CF
(17.32) (73.67) (49.59) (23.27) (47.75) (114.84) (99.85) (42.57) (28.31) 0.00
P/B ratio
24.88 20.77 7.79 3.53 6.84 5.20 3.90 1.23 0.96 0.00
Price to Tangible BV
24.88 20.77 7.79 3.53 6.84 5.20 3.90 1.23 0.96 0.00
EV/Sales
8.78 13.45 13.33 9.04 43.92 74.10 62.85 8.57 0.25 (8.35)
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.00
EV/Operating CF
(4.76) (11.83) (5.74) (3.28) (9.36) (18.06) (18.27) (2.52) (0.16) 0.00
EV/FCF
(4.67) (11.51) (5.65) (3.23) (9.27) (17.76) (17.93) (2.46) (0.15) 0.00
Quick Ratio
2.62 3.89 3.44 5.32 8.07 18.14 22.27 49.81 63.01 56.81
Current Ratio
2.68 4.01 3.58 5.48 8.22 18.32 22.44 50.32 64.53 57.05
Net Debt/EBITDA
0.49 0.73 0.88 1.25 1.41 3.00 3.77 5.96 7.57 (94.95)
Debt/Assets
50.53% 50.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
4.08 2.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.31 0.39 0.26 0.17 0.09 0.05 0.04 0.03 0.03 0.00
Operating CF/Net income
0.77 0.68 0.99 0.83 0.86 0.71 0.70 0.77 0.79 1.67
Capex/Depreciation
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Interest Coverage
(15.78) (13.79) — (56.35) (284.86) (22.43) (9.42) (8.49) (13.08) 1.22
ROE
(397.80%) (139.16%) (80.11%) (66.05%) (55.81%) (29.00%) (21.22%) (12.32%) (3.97%) (12.14%)
ROA
(74.11%) (64.01%) (61.97%) (55.61%) (50.89%) (27.62%) (20.58%) (12.10%) (8.42%) 0.00%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (353.37%) (380.11%) 20.70% 26.74%
Return on Tangible Assets
(118.60%) (78.72%) (116.85%) (88.72%) (70.83%) (33.12%) (24.40%) (13.58%) (4.37%) (6.37%)
Average Days of Receivables
132.92 27.29 59.96 48.37 56.52 92.60 247.19 315.53 366.20 665.62
Research and Development Expense of Revenue
69.72% 58.49% 113.75% 153.62% 349.13% 241.47% 235.34% 256.06% 290.49% 149.34%
Selling, General and Administrative Expense of Revenue
186.44% 175.51% 200.67% 219.14% 278.63% 379.85% 328.35% 349.11% 663.29% 659.21%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
30.10% 32.22% 42.92% 64.46% 74.22% 103.12% 69.66% 36.06% 84.84% 0.00%
Graham Net Nets
0.04 0.05 0.13 0.28 0.14 0.19 0.24 0.80 1.02 0.00
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(26.60%) (11.25%) (15.09%) (24.64%) (10.39%) (6.34%) (5.98%) (10.91%) (5.00%) (5.70%)
Free Cash Flow Yield
(18.96%) (7.96%) (14.93%) (20.94%) (9.05%) (4.52%) (4.21%) (8.64%) (2.72%) 0.00%
Revenue per Share
0.09 0.12 0.10 0.10 0.09 0.06 0.06 0.05 0.03 0.02
Operating CF per Share
(0.17) (0.14) (0.23) (0.28) (0.41) (0.24) (0.21) (0.16) (0.06) (0.17)
Capex per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.17) (0.14) (0.23) (0.28) (0.41) (0.24) (0.21) (0.16) (0.06) (0.17)
Cash per Share
0.26 0.32 0.25 0.45 0.73 1.06 1.27 1.49 1.65 1.54
Shareholders Equity per Share
0.04 0.08 0.20 0.39 0.66 1.04 1.33 1.53 1.73 1.58
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.04 0.08 0.20 0.39 0.66 1.04 1.33 1.53 1.73 1.58
Free Cash Flow
(5.70) (3.97) (6.73) (8.08) (11.28) (6.57) (5.78) (4.41) (1.69) (6.04)
Working Capital
6.21 7.38 5.82 10.97 18.45 28.16 34.05 41.90 48.85 56.62
Net Current Asset Value
1.18 2.37 5.73 10.80 18.10 28.16 34.05 41.90 48.85 56.62
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.00
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 63.08 0.00
Other line items
Depreciation/Fixed assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Cash ROIC
(38.50%) (23.79%) (51.19%) (34.07%) (29.18%) (11.43%) (8.25%) (5.27%) (1.73%) (5.29%)
Accounts Receivable Turnover
4.46 9.48 6.71 7.71 6.17 2.07 1.49 1.38 0.82 0.51
Accounts Payable Turnover
3.48 2.10 2.04 1.50 1.52 1.46 2.33 2.48 1.70 0.53
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
134.05 147.36 121.26 219.41 290.59 259.51 235.90 109.82 279.20 197.35
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
0.69 0.37 0.43 0.38 0.39 0.77 1.13 0.94 0.92 1.17
Average Payables
0.67 0.57 0.97 1.41 1.28 0.98 0.63 0.41 0.40 0.98
Average Assets
9.94 9.07 10.97 17.51 25.69 33.76 40.38 47.02 25.37 0.00
Average Common Equity
1.85 4.17 8.48 14.74 23.42 32.16 39.16 46.21 53.83 29.74

Fold the line items

Columns are period end dates · fundamentals updated 13 Nov 2026